Bair Matthew J, Robinson Rebecca L, Katon Wayne, Kroenke Kurt
Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Arch Intern Med. 2003 Nov 10;163(20):2433-45. doi: 10.1001/archinte.163.20.2433.
Because depression and painful symptoms commonly occur together, we conducted a literature review to determine the prevalence of both conditions and the effects of comorbidity on diagnosis, clinical outcomes, and treatment. The prevalences of pain in depressed cohorts and depression in pain cohorts are higher than when these conditions are individually examined. The presence of pain negatively affects the recognition and treatment of depression. When pain is moderate to severe, impairs function, and/or is refractory to treatment, it is associated with more depressive symptoms and worse depression outcomes (eg, lower quality of life, decreased work function, and increased health care utilization). Similarly, depression in patients with pain is associated with more pain complaints and greater impairment. Depression and pain share biological pathways and neurotransmitters, which has implications for the treatment of both concurrently. A model that incorporates assessment and treatment of depression and pain simultaneously is necessary for improved outcomes.
由于抑郁和疼痛症状通常同时出现,我们进行了一项文献综述,以确定这两种情况的患病率以及共病对诊断、临床结局和治疗的影响。与单独检查这些情况时相比,抑郁人群中疼痛的患病率以及疼痛人群中抑郁的患病率更高。疼痛的存在对抑郁症的识别和治疗产生负面影响。当中度至重度疼痛损害功能和/或对治疗无效时,它与更多的抑郁症状和更差的抑郁结局相关(例如,生活质量较低、工作功能下降和医疗保健利用率增加)。同样,疼痛患者中的抑郁与更多的疼痛主诉和更大的损害相关。抑郁和疼痛共享生物学途径和神经递质,这对同时治疗两者具有重要意义。为了改善结局,需要一个同时纳入抑郁和疼痛评估与治疗的模型。